Get the Stockscreener App
5.17
0.19%
-0.010
After Hours:
5.21
0.04
+0.77%
Evoke Pharma Inc stock is traded at $5.17, with a volume of 19,619.
It is down -0.19% in the last 24 hours and up +3.61% over the past month.
Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.
See More
Previous Close:
$5.18
Open:
$5.1447
24h Volume:
19,619
Relative Volume:
0.01
Market Cap:
$8.06M
Revenue:
$8.62M
Net Income/Loss:
$-6.15M
P/E Ratio:
-0.4687
EPS:
-11.03
Net Cash Flow:
$-5.32M
1W Performance:
-0.77%
1M Performance:
+3.61%
6M Performance:
+40.49%
1Y Performance:
+23.39%
1-Day Range:
$5.10
$5.23
1-Week Range:
$4.9066
$5.26
52-Week Range:
$1.94
$12.32
Evoke Pharma Inc Stock (EVOK) Company Profile
Name
Evoke Pharma Inc
Sector
Phone
858-345-1494
Address
420 STEVENS AVENUE, SOLANA BEACH, CA
Compare EVOK with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
EVOK
Evoke Pharma Inc
|
5.17 | 7.89M | 8.62M | -6.15M | -5.32M | -11.03 |
|
ZTS
Zoetis Inc
|
148.20 | 66.22B | 9.39B | 2.62B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.10 | 48.29B | 29.96B | 957.25M | 4.77B | 0.304 |
|
HLN
Haleon Plc Adr
|
9.81 | 43.99B | 14.26B | 1.98B | 2.47B | 0.4347 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
19.93 | 22.45B | 16.70B | -157.13M | 1.19B | -0.155 |
|
UTHR
United Therapeutics Corp
|
405.02 | 17.93B | 2.99B | 1.21B | 1.13B | 25.06 |
Evoke Pharma Inc Stock (EVOK) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-22-20 | Upgrade | H.C. Wainwright | Neutral → Buy |
| Mar-05-19 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Mar-08-18 | Reiterated | B. Riley FBR, Inc. | Buy |
| Oct-19-17 | Resumed | FBR & Co. | Buy |
| Mar-16-17 | Reiterated | Rodman & Renshaw | Buy |
| Jan-30-17 | Upgrade | Laidlaw | Neutral → Buy |
| Jan-05-17 | Upgrade | Rodman & Renshaw | Neutral → Buy |
| Dec-23-16 | Reiterated | Rodman & Renshaw | Neutral |
| Jul-19-16 | Reiterated | FBR Capital | Outperform |
| Jul-19-16 | Downgrade | Noble Financial | Buy → Hold |
| Jul-18-16 | Downgrade | Rodman & Renshaw | Buy → Neutral |
| Mar-16-16 | Initiated | Northland Capital | Outperform |
| Mar-14-16 | Reiterated | Ascendiant Capital Markets | Buy |
| Feb-17-16 | Resumed | FBR Capital | Outperform |
| Dec-03-14 | Reiterated | MLV & Co | Buy |
| Nov-07-14 | Initiated | MLV & Co | Buy |
| Apr-22-14 | Initiated | Laidlaw | Buy |
| Nov-19-13 | Initiated | Aegis Capital | Buy |
View All
Evoke Pharma Inc Stock (EVOK) Latest News
How to use a screener to detect Evoke Pharma Inc. breakouts2025 Top Decliners & Long-Term Safe Investment Plans - Newser
Historical volatility pattern of Evoke Pharma Inc. visualizedRisk Management & Daily Risk Controlled Trade Plans - Newser
Published on: 2025-09-12 19:04:24 - Newser
Technical signs of recovery in Evoke Pharma Inc.Stop Loss & Daily Stock Trend Reports - Newser
Is it time to cut losses on Evoke Pharma Inc.Trade Risk Summary & Technical Buy Zone Confirmations - Newser
Can trapped investors hope for a rebound in Evoke Pharma Inc.Market Rally & Growth Oriented Trade Recommendations - Newser
Understanding Evoke Pharma Inc.’s price movement2025 Year in Review & Long-Term Capital Growth Ideas - Newser
How to interpret RSI for Evoke Pharma Inc. stockMarket Growth Review & Low Volatility Stock Recommendations - Newser
Combining machine learning predictions for Evoke Pharma Inc.Quarterly Portfolio Report & Technical Confirmation Alerts - Newser
Is this a good reentry point in Evoke Pharma Inc.Risk Management & Daily Risk Controlled Trade Plans - Newser
Tick level data insight on Evoke Pharma Inc. volatilityJuly 2025 Institutional & High Conviction Buy Zone Picks - Newser
Backtesting results for Evoke Pharma Inc. trading strategies2025 Year in Review & Long-Term Capital Growth Ideas - Newser
What candlestick patterns are forming on Evoke Pharma Inc.2025 Retail Activity & Community Verified Swing Trade Signals - Newser
Evoke Pharma Inc. stock momentum explainedWeekly Risk Summary & Community Verified Trade Signals - Newser
Evoke Pharma Inc. stock trendline breakdown2025 Sector Review & Safe Investment Capital Preservation Plans - Newser
Can technical indicators confirm Evoke Pharma Inc.’s reversalJuly 2025 Institutional & Weekly High Potential Stock Alerts - Newser
Chart based analysis of Evoke Pharma Inc. trends2025 Trading Recap & Scalable Portfolio Growth Methods - Newser
Trend analysis for Evoke Pharma Inc. this weekWeekly Volume Report & AI Driven Price Predictions - Newser
Should you hold or exit Evoke Pharma Inc. nowOil Prices & Technical Confirmation Trade Alerts - Newser
Applying Elliott Wave Theory to Evoke Pharma Inc.July 2025 Breakouts & Safe Entry Point Identification - Newser
Will Evoke Pharma Inc. benefit from seasonality2025 Technical Patterns & Smart Allocation Stock Tips - Lancaster City Council
Is Evoke Pharma Inc. stock heavily shortedTreasury Yields & Real-Time Volume Analysis Alerts - Lancaster City Council
Is Evoke Pharma Inc. stock ready for a breakoutJuly 2025 Catalysts & Verified Momentum Stock Ideas - Newser
Is Evoke Pharma Inc. stock entering bullish territoryJuly 2025 Earnings & Weekly Chart Analysis and Guides - Newser
Using fundamentals and technicals on Evoke Pharma IncJuly 2025 Retail & Free Reliable Trade Execution Plans - Newser
Can Evoke Pharma Inc. recover in the next quarter2025 Top Gainers & Free Weekly Watchlist of Top Performers - Newser
Evoke Pharma Inc. stock prediction for this weekAnalyst Upgrade & High Accuracy Swing Trade Signals - Newser
Can Evoke Pharma Inc. rally from current levelsIPO Watch & Weekly High Return Stock Opportunities - Newser
Can you recover from losses in Evoke Pharma Inc.Portfolio Performance Summary & Step-by-Step Swing Trade Plans - Newser
Detecting support and resistance levels for Evoke Pharma Inc.Quarterly Market Summary & Weekly Stock Breakout Alerts - Newser
Can Evoke Pharma Inc. stock outperform in a bear marketSwing Trade & High Return Trade Opportunity Guides - beatles.ru
What is Evoke Pharma Inc. s revenue forecast2025 Market Overview & Weekly High Return Stock Forecasts - خودرو بانک
Evoke Pharma Posts 47 Percent Q2 Growth - AOL.com
What’s the MACD signal for Evoke Pharma Inc.2025 Market Outlook & Daily Growth Stock Tips - خودرو بانک
What is the implied volatility of Evoke Pharma Inc.2025 Market Trends & Low Risk Growth Stock Ideas - خودرو بانک
Is Evoke Pharma Inc. affected by consumer sentimentWeekly Trade Review & Daily Entry Point Trade Alerts - خودرو بانک
What is Evoke Pharma Inc. s 5 year growth outlookIndex Update & Real-Time Chart Pattern Alerts - خودرو بانک
Will Evoke Pharma Inc. outperform its industry peers2025 Market Outlook & Free Safe Capital Growth Stock Tips - خودرو بانک
What’s the recovery path for long term holders of Evoke Pharma Inc.2025 Technical Patterns & Risk Adjusted Swing Trade Ideas - Newser
Evoke Pharma Inc Stock (EVOK) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.67%
0.04%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):